Call us at +1-(707)-743-8122

Login Register cart

The “Master Validation Planning To Meet U.S. FDA cGMP, ISO 13485 and ICH Q9 / ISO 14971 Requirement” webinar will address the need for a company to compile and maintain a Validation Master Plan.  The VMP / MVP lists all the validatable entities in a regulated company, facilities, clean rooms, production and test equipment, processes, products.  It describes what the company requires of each category in terms of validation, verification, preventive maintenance, calibration, re-V&V, et al.  The webinar will discuss working V&V definitions, the supporting documentation addressed by such a plan, including the structure of V&V Test Reports, IQ, OQ and PQ Test Cases.  And how to incorporate patient risk (ISO 14971, ICH Q9) into such V&V planning.

  • Understand published V&V terms definitions and suggested “working definitions”
  • Know the key elements of any VPM
  • Define the key sections of an individual V&V Test Report / Plan
  • “Requirements” and the IQ, OQ, and PQs
  • Test Cases and Sampling
  • Incorporating “Risk” for “risk-based” V&V
  • The strategic overview 

Verification and validation requirements have always been part of the US FDA’s GMPs.  However, with increasing technology, both industry and regulatory agencies expectations have increased.  Recent high-profile field problems indicate that V&V activities are not planned or carried out as completely as expected, are not documented in a top tier Master Validation Plan, and may not be fully utilizing the power of current risk management tools, as identified in ISO 14971.  The FDA / ICH Q-series, including Q9, provide valuable insights for all regulated industries, not just pharma. The billions of dollars spent by industry annually for V&V are not providing the product safety or efficacy seemingly promised.  For most companies, the fixes are not rocket-science, but proper up-front V&V planning and execution, documented in a corporate MVP and implemented by other V&V documents.  

  • Validation Planning elements
  • The Validation Master Plan 
  • Patient / User Risk per ISO 14971 / ICH Q9 hazard analysis / risk management  
  • The individual V&V Plan / protocols  
  • Equipment and process Requirements / DQs, IQs, OQs, and PQs (or equivalents per ASTM E2500)  
  • Software / Firmware “as-product”, “in-product”, process, and equipment, V&V “model”  
  • The QMS V&V and 21 CFR Part 11, Electronic Records / Signatures.

  • Senior management
  • Middle management / operations
  • Production / manufacturing
  • R&D
  • Engineering
  • QA / RA
  • Marketing 

John E. Lincoln is the Principal of J. E. Lincoln and Associates LLC, a consulting company with over 37 years experience in U.S. FDA-regulated industries, 23 of which are as an independent consultant. John has worked with companies from start-up to Fortune 100, worldwide. He specializes in quality assurance, regulatory affairs, QMS problem remediation, and FDA responses, new/changed product 510(k)s, process /product/equipment including QMS and software validations, ISO 14971 product risk management files/reports, Design Control/Design History Files, Technical Files.

He's held positions in Manufacturing Engineering, QA, QAE, Regulatory Affairs, to the level of Director and VP (R&D). In addition, John has prior experience in military, government, electronics, and aerospace. He has published numerous articles in peer-reviewed journals, conducted workshops and webinars worldwide and is also a graduate of UCLA.

View all trainings by this speaker
Live Webinar

Live + Recorded Session

Get unlimited access to the link for one participant, from the date of webinar completion.


Live + Transcript

Get unlimited access to the link for one participant, from the date of webinar completion.


Live + Training CD

Free shipment within 3 to 5 Days from the date of webinar completion.


On Demand


PDF Transcript of the Training which are available once the webinar is completed.(Transcript for single user only)


Downloadable recorded session

Get unlimited access to the link for six months.


Training CD

Free shipment within 72 Hours, from the date of webinar completion


Group Session

Group Session unlimited participants + Recorded

Live session for unlimited participants



Upcoming Webinars